Inhibition of Growth and Induction of Differentiation of SMMC-7721 Human Hepatocellular Carcinoma Cells by Oncostatin M |
Kong, N.
(Department of Regenerative Medicine, College of Pharmacy, Jilin University)
Zhang, X.M. (Department of Regenerative Medicine, College of Pharmacy, Jilin University) Wang, H.T. (Department of Regenerative Medicine, College of Pharmacy, Jilin University) Mu, X.P. (Laboratory of Tang Ao-qing, China-Japan Union Hospital, Jilin University) Han, H.Z. (Journal of Jilin University Medicine Edition, Jilin University) Yan, W.Q. (Department of Regenerative Medicine, College of Pharmacy, Jilin University) |
1 | Blais ME, Louis I, Perreault C (2006). T-cell development: an extrathymic perspective. Immunol Rev, 209, 103-14. DOI ScienceOn |
2 | Brounais B, David E, Chipoy C, et al (2009). Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells. Bone, 44, 830-9. DOI ScienceOn |
3 | Bruce AG, Hoggatt IH, Rose TM (1992). Oncostatin M is a differentiation factor for myeloid leukemia cells. J Immunol, 149, 1271-5. |
4 | Chen SH, Gillespie GY, Benveniste EN (2006). Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases. Glia, 53, 191-200. DOI ScienceOn |
5 | Damdinsuren B, Nagano H, Kondo M, et al (2006). TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells. Oncol Rep, 15, 401-8. |
6 | Guan YS (2006). Hepatocellular carcinoma: the curative attempts. J US-China Med Sci, 3, 59-71. |
7 | Halfter H, Friedrich M, Resch A, et al (2006). Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression. Cancer Res, 66, 6530-9. DOI ScienceOn |
8 | Hamada T, Sato A, Hirano T, et al (2007). Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats. Am J Pathol, 171, 872-81. DOI ScienceOn |
9 | Hay DC, Zhao D, Fletcher J, et al (2008). Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells, 26, 894-902. DOI ScienceOn |
10 | Kamiya A, Gonzalez FJ, Nakauchi H (2006). Identification and differentiation of hepatic stem cells during liver development. Front Biosc, 11, 1302-10. DOI |
11 | Kinoshita T, Miyajima A (2002). Cytokine regulation of liver development. Biochim Biophys Acta, 1592, 303-12. DOI ScienceOn |
12 | Kong N, Mu X, Han H, et al (2009). Pilot-scale fermentation, purification, and characterization of recombinant human oncostatin M in pichia pastoris. Protein Expr Purif, 63, 134-9. DOI ScienceOn |
13 | Kong WJ, Abidi P, Kraemer FB, et al (2005). In vivo activities of cytokine oncostatin M in regulation of plasma lipid levels. J Lipid Res, 46, 1163-71. DOI ScienceOn |
14 | Li WQ, Dehnade F, Zafarullah M (2001). Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol, 166, 3491-8. DOI |
15 | Luyckx VA, Cairo LV, Compston CA, et al (2009). Oncostatin M pathway plays a major role in the renal acute phase response. Am J Physiol Renal Physiol, 296, 875-83. DOI ScienceOn |
16 | Masaki T, Shiratori Y, Rengifo W, et al (2003). Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology, 37, 534-43. DOI ScienceOn |
17 | McCormick C, Freshney RI (2000). Activity of growth factors in the IL-6 group in the differentiation of human lung adenocarcinoma. Br J Cancer, 82, 881-90. DOI ScienceOn |
18 | Morikawa Y (2005). Oncostatin M in the development of the nervous system. Anat Sci Int, 80, 53-9. DOI ScienceOn |
19 | Okaya A, Kitanaka J, Kitanaka N, (2005). Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes. Am J Pathol, 166, 709-19. DOI ScienceOn |
20 | Sensken S, Waclawczyk S, Knaupp AS (2007). In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherap, 9, 362-78. DOI ScienceOn |
21 | Silver JS, Hunter CA ( 2010). gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol, 88, 1145-56. DOI ScienceOn |
22 | Wang CT, Meng M, Zhang JC (2008). Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate. Chin Med J (Engl), 121, 1707-11. |
23 | Sims NA, Walsh NC (2010). GP130 cytokines and bone remodelling in health and disease. BMB Rep, 43, 513-23. DOI ScienceOn |
24 | Song HY, Jeon ES, Jung JS (2005). Oncostatin M induces proliferation of human adipose tissue-derived mesenchymal stem cells. Int J Biochem Cell Biol, 37, 2357-65 DOI ScienceOn |
25 | Tanaka M, Miyajima A (2003). Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol, 149, 39-52. |
26 | Wei X, Wang CY, Liu QP (2008). In vitro hepatic differentiation of mesenchymal stem cells from human fetal bone marrow. J Int Med Res, 36, 721-7. DOI ScienceOn |
27 | Weiss TW, Samson AL, Niego B, et al (2006). Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo. FASEB J, 20, 2369-71. DOI ScienceOn |
28 | West NR, Murphy LC, Watson PH (2012). Oncostatin M suppresses oestrogen receptor- expression and is associated with poor outcome in human breast cancer. Endocr Relat Cancer, 19, 181-95. DOI ScienceOn |
29 | Yamashita Y, Shimada M, Harimoto N, et al (2003). Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer, 103, 572-6. DOI ScienceOn |
30 | Zekri AR, Hassan ZK, Bahnassy AA, et al (2012). Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus. Asian Pac J Cancer Prev, 13, 5433-8. DOI ScienceOn |
31 | Zeng XL, Tu ZG (2003). In vitro induction of differentiation by Ginsenoside Rh2 in SMMC-7721 hepatocarcinoma cell line. Pharmacol Toxicol, 93, 275-83. DOI ScienceOn |